Shanghai, China

Weng K Chan

This inventor holds 1 USPTO granted patent. Top assignee: C. R. Bard, Inc.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weng K Chan: Innovator in Medical Device Technology

Introduction

Weng K Chan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical devices, particularly in catheter technology. His innovative approach has led to the development of a unique catheter insertion device that enhances patient care.

Latest Patents

Weng K Chan holds a patent for a catheter insertion device. This tool is designed for inserting a catheter into a patient's body. The device features a housing that initially contains a portion of the catheter, a needle extending from the housing, and a guidewire partially disposed within the needle. The advancement assembly allows for the distal advancement of the catheter, ensuring a safer and more efficient insertion process.

Career Highlights

Weng K Chan is associated with C. R. Bard, Inc., a company known for its innovative medical technologies. His work has focused on improving the design and functionality of medical devices, contributing to advancements in patient care and treatment options.

Collaborations

Weng K Chan has collaborated with notable colleagues, including Heqing Huang and Jianjiang Chen. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical solutions.

Conclusion

Weng K Chan's contributions to the field of medical devices, particularly through his patented catheter insertion device, highlight his commitment to improving healthcare technology. His work continues to impact patient care positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…